Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Has announcements × Daunorubicin × Clear all

Phase

Status

Sponsor Class

INDUSTRY 4 OTHER 1 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1

Interventions

toripalimab 1 sodium thiosulfate 1 naxitamab 1 Vincristine 1 Rituximab 1 Methotrexate 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Eflornithine 1 Drug Therapy 1 Doxorubicin 1 Daunorubicin 1 Cytarabine 1 Cyclophosphamide 1 Cisplatin 1 Abatacept 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00927498 2013-07-11

A Randomized Study of Gemtuzumab Ozogamicin (GO) With Daunorubicine and Cytarabine in Untreated Acute Myeloid Leukemia (AML) Aged of 50-70 Years Old

Acute Leukemia French Association

Phase 3 Completed

280 enrolled 1 FDA

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡